Dr. Michael G. Mccusker JR., M.D.
Hematology & Oncology (Hematology & Oncology Physician)
- Medicare participating
At a glance
- Medical school
- University of Maryland School of Medicine (2005)
- Years since graduation
- 21
- In the NPI registry since
- 2015
- Medicare patients seen, 2024
- 624
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2005Medical school: University of Maryland School of Medicine
- 2015Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Hematology & Oncology Physician primary
VA license 0101271135
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Winchester Medical Center Winchester, VA
- Warren Memorial Hospital Front Royal, VA
- Shenandoah Memorial Hospital Woodstock, VA
- Hampshire Memorial Hospital Romney, WV
- Valley Health War Memorial Hospital Berkeley Springs, WV
Medical groups
- Shenandoah Oncology PC (23 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 624
- Services billed
- 176,750
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Injection, aprepitant, 1 mg | 16,770 | 54 |
| Injection, pembrolizumab, 1 mg | 15,550 | 33 |
| Injection, oxaliplatin, 0.5 mg | 12,800 | 11 |
| Injection, granisetron, extended-release, 0.1 mg | 10,700 | 28 |
| Injection, paclitaxel, 1 mg | 9,655 | 18 |
| Injection, daratumumab, 10 mg and hyaluronidase-fihj | 7,740 | 12 |
| Injection, denosumab, 1 mg | 5,220 | 20 |
| Injection, dexamethasone sodium phosphate, 1 mg | 2,750 | 86 |
| Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | 2,080 | 12 |
| Injection, ferric derisomaltose, 10 mg | 1,400 | 13 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 4 companies reported 4 payments worth $82.32 in total to this clinician.
| Novartis Pharmaceuticals Corporation | $24.29 |
|---|---|
| EMD Serono, Inc. | $21.35 |
| Merck Sharp & Dohme LLC | $20.45 |
| Pfizer Inc. | $16.23 |
| Food and Beverage | $82.32 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.